CPT Code for Menopause: Billing Guide for 2026
The CPT code for menopause is not a single code. It is a set of Evaluation and Management codes, primarily 99202–99215, paired with ICD-10 diagnosis codes like N95.1 and Z78.0 to document and bill menopause-related clinical encounters. Accurate menopause treatment coding requires matching the right E/M level to documented medical decision-making complexity, then layering in the appropriate diagnosis codes to establish medical necessity. State-level mandates, including recent California policy, now require explicit insurance coverage for menopause evaluation CPT codes in primary care and OB/GYN settings. Getting this right protects your revenue and reduces audit exposure.
What CPT codes are used for menopause office visits?
Menopause office visits use E/M codes 99202–99215, the same codes applied to any problem-oriented outpatient encounter. The specific code you select depends on whether the patient is new or established, and on the documented level of medical decision-making or total provider time.
For established patients, 99213 and 99214 carry the most volume in menopause management. The distinction between them is not arbitrary.
-
99213 (low complexity): Applies to stable patients presenting for routine medication refills, such as a patient on a stable hormone regimen with no new complaints. Medical decision-making is straightforward, and the clinical data reviewed is minimal.
-
99214 (moderate complexity): Applies when a patient presents with new or worsening symptoms, a dosage adjustment, or a side effect requiring evaluation. Code selection hinges on documented medical decision-making complexity, not on how long the visit felt.
-
99215 (high complexity): Reserved for visits involving multiple chronic conditions interacting with menopausal status, or when total provider time exceeds the threshold for moderate complexity. This code is defensible only with thorough documentation.
-
99202–99205 (new patients): New patient codes require documentation of history, examination, and medical decision-making or time. A new patient presenting with perimenopausal symptoms and no prior workup typically warrants 99203 or 99204.
Pro Tip: Document the specific symptoms discussed, the clinical reasoning behind any medication change, and the time spent if you are billing by time. A note that reads “menopause, refill requested” will not support 99214 on audit.
The most common billing error in this category is selecting a code based on habit rather than documentation. Payers audit E/M code distribution, and a practice that bills 99214 for every menopause visit without supporting notes will draw scrutiny.
How are ICD-10 codes paired with CPT codes for menopause billing?
ICD-10 diagnosis codes are the clinical justification behind every CPT code you submit. For menopause, the N95 series and Z78.0 are the primary codes, but they rarely stand alone.
The table below summarizes the most commonly used ICD-10 codes for menopause-related encounters and their appropriate clinical context.
| ICD-10 Code | Description | When to Use |
|---|---|---|
| N95.0 | Postmenopausal bleeding | Abnormal uterine bleeding after menopause |
| N95.1 | Menopausal and female climacteric states | Active symptomatic menopause (hot flashes, night sweats, mood changes) |
| N95.2 | Postmenopausal atrophic vaginitis | Vaginal dryness, dyspareunia related to estrogen deficiency |
| Z78.0 | Asymptomatic menopausal state | Patient is postmenopausal with no active symptoms; used for preventive or monitoring visits |
| R68.0 | Hypothermia, not elsewhere classified (hot flashes) | Symptom-specific code used alongside N95.1 to document hot flashes explicitly |
Z78.0 covers asymptomatic patients aged 15–124 who have completed menopause with no active complaints. N95.1 covers symptomatic menopausal states and is the correct primary code when a patient presents with classic climacteric symptoms.
The critical practice here is dual coding. Submitting N95.1 alone documents the diagnosis, but adding R68.0 for hot flashes or N95.2 for atrophic vaginitis tells the payer exactly what clinical problems were addressed. Combining N95 codes with R-series symptom codes creates a more complete clinical picture and improves reimbursement outcomes.
Pro Tip: Never use Z78.0 as the primary code when a patient has active symptoms. Payers may deny or downcode a claim if the diagnosis code signals an asymptomatic state but the visit note describes active treatment.
The perimenopause symptom list is broader than most billing templates account for. Cognitive symptoms, sleep disruption, and joint pain all have corresponding ICD-10 codes that can be added as secondary diagnoses to reflect the full clinical picture.
Which CPT codes apply to hormone testing in menopause management?
Laboratory testing is a significant part of menopause management, and CPT 82670 is the primary code for estradiol measurement. Billing it correctly requires more than ordering the test.
-
CPT 82670 (estradiol): Used to assess ovarian function, confirm menopausal status, or monitor hormone therapy. Estradiol testing requires a clinical note that ties the test to a specific indication, such as evaluating symptom severity in a patient on hormone therapy or confirming menopause in a patient with an intact uterus.
-
CPT 84146 (prolactin) and CPT 84270 (sex hormone binding globulin): These are sometimes ordered alongside estradiol when evaluating complex hormonal presentations. Each requires its own documented indication.
-
CPT 58100 (endometrial biopsy): Applicable when postmenopausal bleeding (N95.0) is present and tissue sampling is clinically indicated. This procedure code is separate from the E/M code and should be billed with modifier 25 on the office visit if both occur on the same day.
-
CPT 76856 or 76830 (pelvic ultrasound): Used to evaluate endometrial thickness in postmenopausal bleeding. Radiology codes require their own documentation of medical necessity.
The most common pitfall with hormone testing codes is vague documentation. A clinical note that states “menopause, check labs” does not meet medical necessity criteria. Documentation must clearly link the patient’s age, symptoms, current treatment, and the specific clinical question the test is meant to answer. Payers will deny CPT 82670 if the indication is not explicit in the record.
What documentation practices reduce claim denials for menopause care?
Strong documentation is the single most effective tool for protecting menopause-related claims. The following practices address the most common denial triggers.
-
Link every code to a documented clinical problem. Each ICD-10 code on the claim must correspond to a problem addressed in the visit note. If you bill N95.2 for atrophic vaginitis, the note must describe the symptom, the clinical finding, and the treatment plan.
-
Specify medical decision-making elements. For E/M code selection, document the number and complexity of problems addressed, the amount and complexity of data reviewed, and the risk of complications. Medical decision complexity is the primary driver of code level for most menopause visits.
-
Document time when it supports a higher code level. If total provider time, including pre-visit chart review and post-visit documentation, supports 99214 or 99215, record the total minutes in the note.
-
Use symptom-specific codes as secondary diagnoses. Billing N95.1 with R68.0 for hot flashes and a sleep disorder code when applicable gives the payer a complete picture of why the visit was medically necessary.
-
Tie hormone test orders to clinical context. For CPT 82670, the note should state the patient’s age, current hormone therapy status, specific symptoms being evaluated, and the clinical decision the result will inform.
Pro Tip: Audit your own claims quarterly. Pull a sample of menopause-related encounters and verify that each ICD-10 code on the claim appears in the visit note as an addressed problem. This single habit catches the majority of documentation gaps before a payer does.
Regulatory recognition of menopause as medically necessary care is growing. Insurance policies increasingly mandate coverage for menopause evaluation codes, which means payers are also scrutinizing claims more carefully. Solid documentation is both a compliance requirement and a revenue protection strategy.
Key takeaways
Accurate menopause billing requires pairing the correct E/M code with ICD-10 diagnosis codes that reflect the full clinical picture, supported by documentation that explicitly justifies every code on the claim.
| Point | Details |
|---|---|
| E/M code selection | Use 99213 for stable refill visits and 99214 for complex or changing symptom presentations. |
| ICD-10 pairing | Combine N95.1 or N95.2 with symptom-specific R-series codes to establish medical necessity. |
| Hormone testing documentation | CPT 82670 requires a note linking patient age, symptoms, and the clinical question being answered. |
| Dual-coding strategy | Adding secondary diagnosis codes beyond N95.1 improves claim completeness and reduces denial risk. |
| Audit readiness | Quarterly self-audits of menopause claims catch documentation gaps before payers flag them. |
What I have learned from years of menopause coding complexity
The conversation around menopause billing has shifted meaningfully in the past few years, and not just because of updated ICD-10 codes. The bigger change is that payers are paying attention now. Menopause care was historically undercoded and underdocumented, partly because providers assumed it was straightforward and partly because the symptom burden was underestimated in clinical records.
What I have seen consistently is that the practices with the cleanest claim records are the ones that treat every menopause visit the same way they treat a complex chronic disease visit. They document symptom severity. They note what changed since the last visit. They explain why a dosage was adjusted or why a lab was ordered. That level of specificity is not bureaucratic overhead. It is the clinical record doing its job.
The trend toward state-mandated coverage for menopause evaluation codes is a real opportunity for practices that have historically avoided billing these encounters at the appropriate level. But that opportunity comes with scrutiny. Payers who are now required to cover these codes will also audit them more carefully.
My practical advice: build a menopause-specific documentation template that prompts providers to capture symptom severity, treatment rationale, and any labs ordered with their indications. Pair that with a quarterly claim review, and you will see both your denial rate and your audit risk drop. The coding itself is not complicated. The discipline to document consistently is where most practices fall short.
— Amy
Menopause care and the Revive-meds approach to whole-person treatment
Providers navigating menopause management know that the clinical picture extends well beyond hot flashes. Weight changes, metabolic shifts, and mood disruption are part of the same hormonal transition, and they all carry coding implications.
Revive-meds integrates hormone support with metabolic and peptide therapy under one clinician-reviewed care model. For providers and billing specialists who want to understand how menopause weight management intersects with treatment planning, Revive-meds offers detailed clinical resources covering the full scope of menopausal care. All medications are US-compounded at FDA-registered pharmacies and clinician-reviewed before shipment. Explore how Revive-meds approaches peptide and hormone therapy as part of a complete menopause care model.
FAQ
What is the main CPT code for a menopause office visit?
There is no single CPT code for menopause. Providers use E/M codes 99202–99215 based on patient type and documented medical decision-making complexity, with 99213 and 99214 being the most common for established patients.
What ICD-10 code is used for symptomatic menopause?
N95.1 is the primary ICD-10 code for symptomatic menopausal and climacteric states. It should be paired with symptom-specific codes like R68.0 for hot flashes to fully document the clinical picture.
What CPT code covers estradiol testing in menopause management?
CPT 82670 is the standard code for estradiol testing. The clinical note must document the patient’s age, current symptoms, and the specific clinical question the test is intended to answer to support reimbursement.
When should Z78.0 be used instead of N95.1?
Z78.0 applies to asymptomatic postmenopausal patients with no active complaints, typically seen for preventive or monitoring visits. N95.1 is correct when the patient presents with active menopausal symptoms requiring evaluation or treatment.
How do you avoid claim denials for menopause-related billing?
Document every ICD-10 code as an addressed problem in the visit note, specify medical decision-making elements for E/M level selection, and tie all lab orders to explicit clinical indications. Quarterly self-audits of menopause claims catch gaps before payers do.